Redis et al.’s[2] study demonstrated that the higher levels of MYC expression in breast tumor samples were positively associated with CCAT2, and the CCAT2 expression level was suggested as a predictor of metastasis and poor survival for a particular subgroup of breast cancer patients. The gene discussed is CCAT2; the disease is breast cancer.